BNGO · Bionano Genomics, Inc.
$1.18
+0.00 (+0.00%)
At close · Aug 14
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, based on recurring losses from operations incurred since inception, the expectation of continued operating losses, and the need to raise additional capital to finance our future operations, we determined that there is substantial doubt about our ability to continue as a going concern within 12 months after the date that the financial statements included in this Quarterly Report are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$13.90M
Shares
11.78M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-07-10 | New | Biotechnology | $20,000,001 | $20,000,001 | 06b |
| 2024-06-05 | New | Biotechnology | $20,000,000 | $20,000,000 | 06b |
| 2023-10-27 | New | Other Health Care | $35,000,000 | $35,000,000 | 06b |
| 2021-10-25 | New | Other Health Care | $41,850,386 | $41,850,386 | 06b |
Showing 1–4 of 4 filings
Key facts
CIK
1411690
CUSIP
09075F404
13F (30d)
36 filings
36 filers
Visit website
Investor relations